Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
The US market for aesthetic injectables will increase to over $5 billion by 2027, driven primarily by high patient demand, including from emerging patient groups such as men and younger individuals. New product types, such as fat reduction injectables, and the approval of expanded indications for existing products will also contribute to market growth.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for aesthetic injectables in the US across a 10-year period.
Increasing competition is forcing companies to further invest in marketing efforts to gain or maintain shares in the market.
What new marketing methods are being implemented by competitors?
Which companies have benefited the most from successful marketing campaigns?
How will marketing initiatives differ between established companies and new market entrants?
How are companies marketing to new patient demographics such as men and millennials?
Several new South Korean and domestic competitors are set to enter the US market either directly or through partnerships.
Which companies are involved in partnerships?
What products are involved in such agreements?
How will companies differentiate their products in an era of increasing commoditization?
Several novel treatments will impact the aesthetic injectable market through 2027.
What impact will new products such as cellulite reduction injectables and biostimulatory dermal fillers have on the aesthetic injectable market?
What share will nonfacial treatments have in the overall market? How will this market grow?
Already a Client? Log in to access this report.
Robert is an analyst within the Endoscopy and Aesthetics Medtech Insights team at Decision Resources Group, specializing in the fields of aesthetic injectables and cosmetic threads. Robert holds an Honors Bachelor's degree in Immunology from McGill University.